David Byres
Biographic Data
| ID | 7448540 |
|---|---|
| NAME | David Byres |
| GIVEN NAMES | David |
| FAMILY NAME | Byres |
| SIGNATURE | BYRES D |
| AFFILIATIONS | Provincial Health Services Authority |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
How injectable opioid agonist treatment (iOAT) care could be improved? service providers and stakeholders’ perspectives
Background Addressing inadequacies in the implementation of existing evidence-based approaches into practice, such as injectable opioid agonist treatment (iOAT), is imperative for the management of opioid use disorder. With the expansion of iOAT, stakeholder perspectives are needed to inform program optimization. This study aimed to understand stakeholder and provider perspectives on iOAT care and how it can be improved to better meet service use…
Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling)
Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the Covid-19 pandemic: A qualitative systematic review
No prominent works on this page.
Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling)
Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the Covid-19 pandemic: A qualitative systematic review
How injectable opioid agonist treatment (iOAT) care could be improved? service providers and stakeholders’ perspectives
Background Addressing inadequacies in the implementation of existing evidence-based approaches into practice, such as injectable opioid agonist treatment (iOAT), is imperative for the management of opioid use disorder. With the expansion of iOAT, stakeholder perspectives are needed to inform program optimization. This study aimed to understand stakeholder and provider perspectives on iOAT care and how it can be improved to better meet service use…
Business (2 works) · Focus group (2 works) · HIV, Drug Use, Sexual Risk (2 works) · Marketing (2 works) · Opioid Use Disorder Treatment (2 works) · Political science (2 works) · Substance Abuse Treatment and Outcomes (2 works) · Applied Psychology (1 works) · Autonomy (1 works) · Buprenorphine (1 works)